Cargando…
PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
OBJECTIVE: To investigate the correlation between serum parathyroid hormone (PTH) levels and in-hospital major adverse cardiovascular events (MACE) in patients with acute ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI), and establish a risk p...
Autores principales: | Wu, Zu-Fei, Su, Wen-Tao, Chen, Shi, Xu, Bai-Da, Zong, Gang-Jun, Fang, Cun-Ming, Huang, Zheng, Hu, Xue-Jun, Wu, Gang-Yong, Ma, Xiao-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460584/ https://www.ncbi.nlm.nih.gov/pubmed/37641783 http://dx.doi.org/10.2147/TCRM.S420335 |
Ejemplares similares
-
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014) -
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016) -
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020) -
Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Li, Yan, et al.
Publicado: (2020) -
Serum VCAM‐1 and ICAM‐1 measurement assists for MACE risk estimation in ST‐segment elevation myocardial infarction patients
por: Yu, Jiancai, et al.
Publicado: (2022)